Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies
Lancet Neurol 7:1091-1098, Dalmau,J.,et al, 2008
Low-Dose Clozapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease
NEJM 340:757-763,801, The Parkinson Study Group, 1999
Managing the Late Complications of Parkinson's Disease
Neurol 49:549-557, Waters,C.H., 1997
Low-Dose Clozapine in the Treatment of Levodopa-Induced Mental Disturbances in Parkinson's Disease
Neurol 45:432-434, Rabey,J.M.,et al, 1995
Psychosis in Advanced Parkinson's Disease:Treatment with Ondansetron, a 5-HT3 Receptor Antagonist
Neurol 45:1305-1308, Zoldan,J.,et al, 1995
Olanzapine in the Treatment of Dopaminomimetic Psychosis in Patients with Parkinson's Disease
Neurol 47:1085-1087, Wolters,W.Ch.,et al, 1992
Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Cocaine
Adams & Victors Principles of Neurology Chp 43, pg 1213, Ropper, A.H.,et al, 2014
Clinical Features and Pharmacologic Treatment of Behavioral Symptoms of Alzheimer's Disease
Neurol 48 (Suppl 6) :S17-S24997., Borson,S.&Raskind,M.A., 1997
Valproic Acid for the Treatment of Children with Mental Retardation and Mood Symptomatology
Pediatrics 86:467-472, Kastner,T.,et al, 1990
Forced Normalization, Acute Psychosis After Seizure Control in Seven Patients
Arch Neurol 44:289-292, Pakalnis,A.,et al, 1987
De Novo Minor Status Epilepticus of Late Onset Presenting as Stupor
BMJ 287:1673-1674, Spriggs,E.A., 1983
Phencyclidine:The New American Street Drug
Editorial, BMJ 281:1511-15121980., , 1980
Microangiopathy of the Brain & Retina
Neurol 29:313-316, Susac,J.O.,et al, 1979
Prolonged Partial Complex Status Epilepticus:EEG & Behavioral Observations
Neurol 28:863-869, Engel,J.Jr.,et al, 1978
Pneumocephalus
In:Vinken P. J. & Bruyn, G. W. Ed, Handbook of Clinical Neurology, Vol 24, North-Holland Publ Co, Am, terdam, 197Markham, J. W., 1976